Multiplex ddPCR assay for screening copy number variations in BRCA1 gene

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


Purpose: Germinal and somatic rearrangements in BRCA1 gene play a significant role in carcinogenesis of breast and ovarian cancer. The present study is dedicated to the development of multiplex droplet digital PCR (ddPCR) assay for detecting large deletions and duplications in the BRCA1 gene. Methods: In-house tetraplex ddPCR assay for BRCA1 gene analysis was used for testing of DNA samples with BRCA1 status. Results: DNA specimens were purified from 24 individuals. The presence of BRCA1 rearrangements in samples was confirmed by a commercial MLPA-based kit. An amplitude-based multiplex ddPCR assay was developed: 8 multiplexes, each containing primers and probes to amplify 3 BRCA1 exons and 1 reference gene (ALB or RPP30). A novel assay demonstrated 100% concordance with the commercial MLPA-based kit, identifying 9 specimens with different deletions in BRCA1, 1 with duplication, and 14 with the wild-type BRCA1. Conclusions: We have designed a simple, precise, and cost-effective assay for BRCA1 rearrangement testing, based on ddPCR. The developed assay is the first multiplex ddPCR-based test that provides results in accordance with MLPA and can be used for routine clinical screening.

Original languageEnglish
Pages (from-to)545-555
Number of pages11
JournalBreast Cancer Research and Treatment
Issue number3
Publication statusPublished - 1 Dec 2019


  • BRCA1
  • CNV
  • Digital PCR
  • Gene rearrangements
  • Multiplex amplification


Dive into the research topics of 'Multiplex ddPCR assay for screening copy number variations in BRCA1 gene'. Together they form a unique fingerprint.

Cite this